Caption Management, LLC Ultragenyx Pharmaceutical Inc. Call Options Transaction History

Caption Management, LLC

$5.74 Billion
Q3 2024

Call Options

17 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$40.21 - $59.36 $1.21 Million - $1.78 Million	30,000 New	30,000 $1.67 Million
Q1 2024 May 15, 2024	SELL	$43.02 - $53.69 $275,328 - $343,616	-6,400 Reduced 21.33%	23,600 $1.1 Million
Q4 2023 Feb 14, 2024	BUY	$31.73 - $49.19 $237,975 - $368,925	7,500 Added 33.33%	30,000 $1.43 Million
Q3 2023 Nov 14, 2023	SELL	$34.92 - $46.66 $2.36 Million - $3.15 Million	-67,500 Reduced 75.0%	22,500 $802,000
Q2 2023 Aug 14, 2023	BUY	$37.35 - $52.15 $2.24 Million - $3.13 Million	60,000 Added 200.0%	90,000 $4.15 Million
Q1 2023 May 15, 2023	BUY	$36.99 - $48.71 $369,900 - $487,100	10,000 Added 50.0%	30,000 $1.2 Million
Q4 2022 Feb 14, 2023	SELL	$33.72 - $46.33 $3.47 Million - $4.77 Million	-102,900 Reduced 83.73%	20,000 $926,000
Q3 2022 Nov 14, 2022	SELL	$39.96 - $66.14 $1.6 Million - $2.65 Million	-40,000 Reduced 24.55%	122,900 $5.09 Million
Q2 2022 Aug 15, 2022	BUY	$45.8 - $85.4 $4.81 Million - $8.97 Million	105,000 Added 181.35%	162,900 $9.72 Million
Q1 2022 May 13, 2022	BUY	$62.2 - $84.4 $3.6 Million - $4.89 Million	57,900 New	57,900 $4.2 Million
Q2 2021 Aug 16, 2021	SELL	$92.19 - $115.71 $4.09 Million - $5.14 Million	-44,400 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$106.9 - $167.73 $1.82 Million - $2.85 Million	17,000 Added 62.04%	44,400 $5.06 Million
Q4 2020 Feb 16, 2021	BUY	$84.4 - $177.39 $33,760 - $70,956	400 Added 1.48%	27,400 $3.79 Million
Q3 2020 Nov 16, 2020	SELL	$72.98 - $90.0 $1.91 Million - $2.36 Million	-26,200 Reduced 49.25%	27,000 $2.22 Million
Q2 2020 Aug 14, 2020	BUY	$46.91 - $78.22 $2.5 Million - $4.16 Million	53,200 New	53,200 $4.16 Million
Q2 2019 Aug 13, 2019	SELL	$54.93 - $74.36 $1.37 Million - $1.86 Million	-25,000 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$39.87 - $69.36 $996,749 - $1.73 Million	25,000 New	25,000 $1.73 Million

Others Institutions Holding RARE

# of Institutions

325

Shares Held

85.5M

Call Options Held

520K

Put Options Held

406K

Vanguard Group Inc Valley Forge, PA

9.95M
Shares

$427 Million
0.01% of portfolio
Black Rock Inc. New York, NY

5.6M
Shares

$241 Million
0.01% of portfolio
Sands Capital Management, LLC Arlington, VA

5.12M
Shares

$220 Million
0.91% of portfolio
Wellington Management Group LLP Boston, MA

4.17M
Shares

$179 Million
0.04% of portfolio
Price T Rowe Associates Inc Baltimore, MD

3.07M
Shares

$132 Million
0.02% of portfolio

View Full List

About Ultragenyx Pharmaceutical Inc.

Ticker RARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,036,896
Market Cap $3.01B
Description
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...

More about RARE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Caption Management, LLC with notifications on news.

Account